Le Lézard
Classified in: Business
Subject: SHAREHOLDER RIGHTS PLANS

International Petroleum Corporation Updated Share Capital


TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) reports the following, in accordance with the Swedish Financial Instruments Trading Act:

Following the cancellation of 572,506 common shares repurchased by IPC under the normal course issuer bid / share repurchase program, the total number of issued and outstanding common shares of the Corporation is 125,898,960 common shares with voting rights as at February 29, 2024, of which IPC holds 70,600 common shares in treasury.

International Petroleum Corp. (IPC) is an international oil and gas exploration and production company with a high quality portfolio of assets located in Canada, Malaysia and France, providing a solid foundation for organic and inorganic growth. IPC is a member of the Lundin Group of Companies. IPC is incorporated in Canada and IPC's shares are listed on the Toronto Stock Exchange (TSX) and the Nasdaq Stockholm exchange under the symbol "IPCO".

For further information, please contact:

 Rebecca Gordon
SVP Corporate Planning and Investor Relations
[email protected]
Tel: +41 22 595 10 50


Or
Robert Eriksson
Media Manager
[email protected]
Tel: +46 701 11 26 15
    

This information is information that International Petroleum Corporation is required to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the contact persons set out above, at 17:30 CET on February 29, 2024.

 



These press releases may also interest you

at 03:41
TDR Capital and I Squared Capital are pleased to announce their successful offer for the Spanish certification company, Applus Services S.A. Applus is one of the world's leading testing, inspection and certification (TIC) companies. Applus reported...

at 03:38
Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months. January ? March...

at 03:30
CLEVR is delighted to announce that PREMIUM INC. a Dutch house of athleisure-wear brands has selected and implemented the Mendix Digital Lifecycle Management for Fashion & Retail solution to help support its expansion. The entrepreneurial culture and...

at 03:00
ISX Financial EU PLC ("ISXPlc"), is pleased to present its earnings for Q1 2024. Building on the back of a record Q4 23, ISXPlc is pleased to have delivered yet another record breaking quarter, marking a continuation of its upward trajectory and...

at 03:00
ShapeBlue, a leader in delivering CloudStack engineering services and support, announces a partnership with proIO, a German Private Cloud Provider empowering SMBs across various industries through its Infrastructure-as-a-Service and Managed Hosting...

at 03:00
SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company developing emactuzumab...



News published on and distributed by: